经鼻高流量湿化氧疗对呼吸衰竭患者治疗的研究进展

Research progress of high-flow nasal cannula humidified oxygen therapy in patientswith respiratory failure

摘要:

氧疗是急性呼吸衰竭的一线治疗策略,其中非侵入性氧疗包括无创正压通气(NPPV)、标准氧(鼻导管吸氧)和经鼻高流量(HFNC)湿化氧疗。HFNC是新型辅助呼吸方式,近几年在临床上得到快速普及并推广。虽然HFNC是一种新型的呼吸支持技术,但其在临床的规范使用和适用范围尚需进一步临床研究。为了能更好地挽救患者生命,并积极促进患者早日康复,本文通过查阅相关文献,对比HFNC、标准氧和NPPV的治疗效果,以明确HFNC的治疗优势。

Abstract:

Oxygen therapy is the first-line treatment strategy for acute respiratory failure. Non-invasive oxygen therapy includes non-invasive positive pressure ventilation (NPPV), standard oxygen (oxygen inhalation through nasal cannula), and high-flow nasal cannula (HFNC) humidified oxygen therapy. HFNC is a new type of assisted breathing and has been rapidly popularized in clinical practice in recent years. However, HFNC is a new respiratory support technique, but how to standardize its use in clinical practice and to clarify its applicable scope still needs further clinical research. In order to better save patients′ lives and actively promote patients′ early recovery, this paper clarifies the therapeutic advantages of HFNC by comparing its efficacy with that of standard oxygen and NPPV.